logo-loader
viewArcadia Biosciences Inc

Arcadia Biosciences unveils new tie-up for supply of Hawaiian grown and extracted ingredients in North America

The new partnership is between Vivion and Archipelago Ventures - the firm's joint venture with Legacy Ventures Hawaii

Arcadia Biosciences Inc -
VSI will be Archipelago's North American distributor, managing marketing and sales of the ingredients in key markets like food and beverage, human and pet nutrition

Arcadia Biosciences (NASDAQ:RKDA), the crop science firm, has announced a tie-up with Vivion Specialties Inc (VSI) to distribute its first Hawaiian grown and extracted ingredients throughout North America.

The new partnership is between Vivion and Archipelago Ventures - the firm's joint venture with Legacy Ventures Hawaii to grow and extract high-quality hemp and derivatives on the islands.

READ: Arcadia Biosciences partners with two companies to introduce its GoodHemp seed line to California growers

VSI will be Archipelago's North American distributor, managing marketing and sales of the ingredients in key markets like food and beverage, human and pet nutrition, with sales expected later this year.

"When it comes to hemp and hemp-derived products like cannabidiol (CBD), ingredient transparency and quality control are a high priority for discerning retailers and shoppers," Arcadia CEO Matthew Plavan said in a statement.

"With VivAssure, Vivion Specialties has pioneered a new and rigorous standard for the testing and certification of hemp ingredients. What's more, Vivion is an experienced specialty ingredient supplier with a network of 18 sales regions in the U.S. and Canada, making them an ideal partner to distribute what we expect will be the first Hawaiian-grown, Hawaiian-extracted CBD ingredients available in North America."

Archipelago's Hawaiian hemp products will be marketed as meeting VivAssure product standards, namely free of over 950 pesticides and contaminants, 24 heavy metals and a variety of microbial organisms, and contain the precise tetrahydrocannabinol (THC) content and CBD profile listed.

"For more than sixty years, Vivion Inc has prioritized providing customers with the highest quality product ingredients across the food and beverage, human and pet nutrition and personal care markets," VSI CEO and Founder and Vivion Inc president Michael Poleselli added.

"Through our partnership with Archipelago and Arcadia Biosciences, a leader in hemp innovation, we're applying these capabilities to one of the most exciting and in-demand new consumer product categories: hemp-derived CBD."

Shares in New York eased 1.95% to $2.51 each.

---Updates for share price---

Contact the author at [email protected]

Quick facts: Arcadia Biosciences Inc

Price: 3.64 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $36.57 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Arcadia Biosciences raises $6.8M to fund hemp opportunities, cushion from...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matt Plavan tells Proactive that the agricultural technology company has raised about $6.8 million by selling warrants. Plavan says the company expects to use the proceeds to pursue a range of near-term inorganic growth opportunities within its hemp...

1 week, 6 days ago

2 min read